Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Pfizer reveals new series of nicotinic acetylcholine receptor-modulating agents

Aug. 17, 1999

Therapeutic Antibodies submits PLA and ELA for DigiTAb

Aug. 12, 1999

BP-897, a partial dopamine D3 receptor agonist with potential in treating cocaine dependency

Aug. 2, 1999

Lilly designs selective 5-HT1A antagonists especially for nicotine/tobacco withdrawal

July 12, 1999

LecTec granted patents on cotinine for smoking cessation and psychiatric disorders

July 7, 1999

Orphan Medical's Antizol injection receives approval in the U.K.

June 29, 1999

Cantab's vaccine for cocaine addiction shows encouraging phase I results

June 18, 1999

M-100907: a potential treatment for coexisting cocaine dependence and schizophrenia

May 26, 1999

Systematic review of published studies questions efficacy of carbamazepine in cocaine dependency

May 26, 1999

Slow-release naltrexone enters the clinic

April 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...